Dmitry Sergeevich Khvan

Dmitry Sergeevich Khvan

Auto-generated profile, based on publicly available information

Dmitry Sergeevich Khvan

Meshalkin National Medical Research Center

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 December 2018 in Russian Journal of Cardiology
Verified
Journal Article
Open access
PDF file
АCАлександр Михайлович Chernyavskiy
Александр Михайлович Chernyavskiy
MLM. M. Lyashenko
M. M. Lyashenko
DSD. A. Syrota
D. A. Syrota
DKD. S. Khvan
D. S. Khvan
BKBoris Kozlov
Boris Kozlov
Vitaliy Leonidovich LukinovVitaliy Leonidovich Lukinov
Vitaliy Leonidovich Lukinov
Aim. To assess results of Meshalkin National Research Medical Center and Tomsk National Research Medical Center in surgical treatment of DeBakey type I aortic dissection using hybrid technologies (“frozen elephant trunk”) compared with classical standard interventions.Material and methods. The study included patients operated on successively in the 2002­2010 timeframe with a diagnosis of acute and subacute DeBakey type I aortic dissection. A retrospective observational comparison of the surgical treatment results of patients (two groups) was performed: using standard surgical approaches (beveled anastomosis or aortic arch replacement using multi­branched prosthesis) and frozen elephant trunk (FET) intervention. The groups included 70 and 31 patients, respectively. Mortality and morbidity were evaluated in the postoperative period, the frequency of aorto­related events — during the observation period.Results. Mortality and the frequency of complications between the groups in the early and late postoperative periods did not differ. Aorto­related events of the groups in the long­term period differed statistically significantly in favor of hybrid interventions (p=0,005).Conclusion. The hybrid technology of thoracic aorta reconstruction using “frozen elephant trunk” type allows to make one­step reconstruction of the aorta during its multilevel lesion. Observation of patients in the long­term period allows us to announce of a longtime, stable result of surgical treatment in the absence of additional perioperative risks.

14 September 2020 in Russian Journal of Cardiology
Verified
Journal Article
Open access
PDF file
AFA. V. Fomichev
A. V. Fomichev
DKD. S. Khvan
D. S. Khvan
HAH. A. Agaeva
H. A. Agaeva
MZM. O. Zhulkov
M. O. Zhulkov
DDD. V. Doronin
D. V. Doronin
АCАлександр Михайлович Chernyavskiy
Александр Михайлович Chernyavskiy
Aim. A retrospective analysis of the outcomes of heart transplantation (HT) with extended cold ischemic time of donor heart (more than 4 hours) versus heart transplantation with short cold ischemia time (less than 4 hours).Material and methods. The retrospective analysis included 52 recipients who underwent HT in the period from July 20, 2012 to October 23, 2019 in Meshalkin National Medical Research Center. The patients were divided into two groups: group 1 (n=26) — orthotopic HT with extended cold ischemic time (more than 240 minutes), group 2 (n=26) — short cold ischemia time (less than 240 minutes). The effect of cold ischemia duration on hospital survival, the function of donor heart, and the postoperative course was assessed.Results. A retrospective analysis revealed a higher rate of hospital survival in the group of recipients with extended cold ischemic time (more than 240 minutes) 88,5% compared to 80,7% in the second group. There was no difference between the groups in the acute rejection rate, the need for inotropic agents, mechanical circulatory support, and cardiac pacing, as well as the incidence of postoperative renal failure and infectious complications.Conclusion. Due to the small number of patients, our experience in HT with extended cold ischemic time does not allow us to draw global conclusions, but a preliminary comparison of HT with extended and short cold ischemic time did not reveal significant advantages in one group or another. This provides a basis for further accumulation of experience and research.

10 May 2022 in Global Heart
Verified
Journal Article
Open access
PDF file
TBTemirkhan Begisbayev
Temirkhan Begisbayev
LKLyazzat Kosherbayeva
Lyazzat Kosherbayeva
VAValikhan Akhmetov
Valikhan Akhmetov
DKDmitry Khvan
Dmitry Khvan
MBMarzhan Brimzhanova
Marzhan Brimzhanova
Implantation of implantable cardioverter-defibrillators (ICD) has increased significantly over the past decade. However, limited data exist regarding practices and policies of ICD implantations in Kazakhstan. We aimed to provide an overview of the current use of ICD in Kazakhstan. Using the Unified Healthcare Information System database of the entire Kazakh adult population, statistical and cost data of ICD implantations in 2017–2019 were evaluated. Cardiologists and electrophysiologists working in cardio surgery centers and departments were asked to go through an online survey focused on subcutaneous-ICD (S-ICD) experience. Implantation of traditional transvenous cardioverter-defibrillators for residents of Kazakhstan is fully reimbursed. A total of 2,263 ICD interventions (2,252 new implantations and 11 reimplantations) were performed across the country during the study period. According to the tariffs approved by the Ministry of Health, the reimbursement cost for one ICD case is about 14,061.80 US dollars. The survey showed that only two hospitals have implanted S-ICDs. Among the main reasons why S-ICD is not widely used in the country the following were named: lack of trained staff (61.1% of respondents); the cost of device and lack of reimbursement (38.7%); and lack of pacing function (27.8%). The number of ICD implantation in Kazakhstan is steadily continuing to grow, although, compared to developed countries, the implantation rate especially for S-ICD remains low. There is a need in deliberate strategies to remove policy barriers for implementation the most innovative cardiac implantable electronic devices implantations such as S-ICD in the country.

3 July 2020 in Patologiya krovoobrashcheniya i kardiokhirurgiya
Verified
Journal Article
Open access
PDF file
САС. А. Альсов
С. А. Альсов
VTV. Tsirikhov
V. Tsirikhov
ДСД. А. Сирота
Д. А. Сирота
DKD. Khvan
D. Khvan
MLM. Lyashenko
M. Lyashenko
ВЦВ. Р. Цирихов
В. Р. Цирихов
This article presents our experience of using an operating microscope for coronary-artery bypass surgery. The technique, which was developed by the surgeons of Meshalkin National Medical Research Center, involves the use of an operating microscope for performing anastomosis and presents with major difficulties and disadvantages. This paper aims to simplify the procedure of performing anastomosis during coronary-artery bypass surgery using an operating microscope.Received 28 February 2020. Revised 24 March 2020. Accepted 25 March 2020.Funding: The study did not have sponsorship.Conflict of interest: Authors declare no conflict of interest.

30 August 2024 in Patologiya krovoobrashcheniya i kardiokhirurgiya
Verified
Journal Article
Open access
PDF file
ASA.K. Sabetov
A.K. Sabetov
DSD.A. Sirota
D.A. Sirota
DKD.S. Khvan
D.S. Khvan
MZM.O. Zhulkov
M.O. Zhulkov
ASAldar Shadanov
Aldar Shadanov
АCАлександр Михайлович Chernyavskiy
Александр Михайлович Chernyavskiy
Objective: The aim of this study was to evaluate the outcomes of autoarterial revascularization involving Y-composite grafts and in situ conduits out of the internal thoracic arteries (ITAs) at the hospital period and after a year follow-up.Methods: The study included 200 patients with coronary artery disease who underwent coronary bypass surgery over the period from March 2018 to March 2021. Patients were randomized using the envelope method into 2 groups: in the first group, autoarterial conduits out of the ITAs were used according to the in situ method (n = 100); in the second group, autoarterial conduits with the formation of a Y-composite grafts out of ITAs (n = 100) were put into practice. The primary endpoints of the study were the incidence of repeat revascularization and amount of major adverse cardiac and cerebrovascular events (MACCE).Results: There was no significant difference between the two groups in the level of freedom from MACCE; in the in situ and Y-composite groups the indicators were 97.9% (95% CI 92.1-99.5) and 94.8% (95% CI 88.1‑97.8; P = 0.24), respectively. In a year follow-up, freedom from repeated revascularization amounted to 97.9% in the in situ group (95% CI 92-99.4), and 97.9% in the Y-composite group (95% CI 91.9-99.4; P = 0.97). A significant difference was registered in the surgery duration, which in the in situ group lasted 235 [197.5; 252.5] minutes versus 252.5 [225; 290] minutes in the Y-composite group, P < 0.002. In the Y-composite group, the rate of infectious complications on the breast bone was significantly more frequent than in the in situ group (P < 0.023).Conclusion: Despite the hypothetical advantages of bimammar coronary bypass surgery over the Y-configuration one, this study did not reveal significant differences in outcomes between the in situ and Y-composite groups. Received 7 November 2023. Revised 10 June 2024. Accepted 24 June 2024. FundingThe study did not have sponsorship. Conflict of interestThe authors declare no conflict of interest. Contribution of the authorsConception and study design: A.K. Sabetov, D.S. Khvan, M.O. ZhulkovData collection and analysis: A.K. SabetovStatistical analysis: A.A. Shadanov, A.K. SabetovDrafting the article: A.K. SabetovCritical revision of the article: D.A. Sirota, D.S. Khvan, A.M. ChernyavskiyFinal approval of the version to be published: A.K. Sabetov, D.A. Sirota, D.S. Khvan, M.O. Zhulkov, A.A. Shadanov, A.M. Chernyavskiy

27 June 2018 in Russian Journal of Transplantology and Artificial Organs
Verified
Journal Article
Open access
PDF file
DKD. S. Khvan
D. S. Khvan
ACA. M. Chernyavsky
A. M. Chernyavsky
VEV. U. Efendiev
V. U. Efendiev
DSD. A. Sirota
D. A. Sirota
DDD. V. Doronin
D. V. Doronin
MZM. O. Zhulkov
M. O. Zhulkov
Больные с терминальной сердечной недостаточностью, рефрактерной к медикаментозной терапии, являются тяжелой категорией кардиологических больных. Доказана возможность эффективной коррекции полиорганной недостаточности и увеличение продолжительности жизни пациентов с критической сердечной недостаточностью при использовании устройств вспомогательного кровообращения. В данном сообщении мы приводим случай имплантации бивентрикулярного вспомогательного устройства кровообращения «Berlin Heart EXCOR» в качестве моста к ортотопической трансплантации сердца пациенту с дилатационной кардиомиопатией, критической сердечной недостаточностью и высокой степенью риска фатальных осложнений. Несмотря на тяжелый, длительный послеоперационный период после имплантации устройства «Berlin Heart EXCOR», протекавший с явлениями обратимой полиорганной, сердечной недостаточности, дисфункции насосов бивентрикулярной экстракорпоральной системы, удалось достигнуть стабилизации состояния больного, регресса явлений сердечной недостаточности и через 9 месяцев выполнить ортотопическую трансплантацию сердца с хорошим отдаленным результатом.